A comprehensive view of biopharmaceuticals/biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA clears Bristol Myers Squibb’s Breyanzi lisocabtagene maraleucel cell therapy to treat large B-cell lymphoma in patients not eligible for stem cell transplant; drug uses genetically modified immune cells that fight cancer
Published: June 28, 2022 by SeeNews Pharmaceuticals
Global regenerative medicine market expected to grow to US$83.19B by 2030, with CAGR growth of 23.4% from 2021 to 2030; growth to be driven by rise in chronic diseases and trauma emergencies, increasing adoption of stem cell technology and nanotechnology
Published: June 27, 2022 by PR Newswire
MilliporeSigma opens US$65M, 70,000 square-foot expansion at facility in Verona, Wisconsin, doubling production capacity to make high-potent active pharmaceutical ingredients; demand for HPAIPs growing for cancer treatments
Published: June 27, 2022 by Canada Newswire
Global soft tissue repair market expected to grow to US$17.2B by 2027, with CAGR growth of 4.7% from 2022 to 2027; growth driven by increases in obesity, cardiovascular diseases, trauma, growing need to manage patient blood loss, increasing R&D in field
Published: June 27, 2022 by PR Newswire
Invectys partners with MD Anderson Cancer Center, Cell Therapy Manufacturing Center to develop process to create human leukocyte antigen targeted chimeric antigen receptor T cell therapy to treat solid tumors; process to use Invectys’ HLA-G platform
Published: June 21, 2022 by Marketline - Deals

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count